Literature DB >> 12746500

Specificity of short interfering RNA determined through gene expression signatures.

Dimitri Semizarov1, Leigh Frost, Aparna Sarthy, Paul Kroeger, Donald N Halbert, Stephen W Fesik.   

Abstract

Short interfering RNA (siRNA) is widely used for studying gene function and holds great promise as a tool for validating drug targets and treating disease. A critical assumption in these applications is that the effect of siRNA on cells is specific, i.e., limited to the specific knockdown of the target gene. In this article, we characterize the specificity of siRNA by applying gene expression profiling. Several siRNAs were designed against different regions of the same target gene for three different targets. Their effects on cells were compared by using DNA microarrays to generate gene expression signatures. When the siRNA design and transfection conditions were optimized, the signatures for different siRNAs against the same target were shown to correlate very closely, whereas the signatures for different genes revealed no correlation. These results indicate that siRNA is a highly specific tool for targeted gene knockdown, establishing siRNA-mediated gene silencing as a reliable approach for large-scale screening of gene function and drug target validation.

Mesh:

Substances:

Year:  2003        PMID: 12746500      PMCID: PMC164449          DOI: 10.1073/pnas.1131959100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  RefSeq and LocusLink: NCBI gene-centered resources.

Authors:  K D Pruitt; D R Maglott
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  RNA aptamers as effective protein antagonists in a multicellular organism.

Authors:  H Shi; B E Hoffman; J T Lis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

3.  Expression analysis using DNA microarrays demonstrates that E2F-1 up-regulates expression of DNA replication genes including replication protein A2.

Authors:  Y Kalma; L Marash; Y Lamed; D Ginsberg
Journal:  Oncogene       Date:  2001-03-15       Impact factor: 9.867

4.  Orc6 involved in DNA replication, chromosome segregation, and cytokinesis.

Authors:  Supriya G Prasanth; Kannanganattu V Prasanth; Bruce Stillman
Journal:  Science       Date:  2002-08-09       Impact factor: 47.728

Review 5.  A good antisense molecule is hard to find.

Authors:  A D Branch
Journal:  Trends Biochem Sci       Date:  1998-02       Impact factor: 13.807

6.  Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways.

Authors:  Dianne S Schwarz; György Hutvágner; Benjamin Haley; Phillip D Zamore
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

7.  Multiclass cancer diagnosis using tumor gene expression signatures.

Authors:  S Ramaswamy; P Tamayo; R Rifkin; S Mukherjee; C H Yeang; M Angelo; C Ladd; M Reich; E Latulippe; J P Mesirov; T Poggio; W Gerald; M Loda; E S Lander; T R Golub
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

Review 8.  Antisense oligonucleotides: promise and reality.

Authors:  I Lebedeva; C A Stein
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

9.  Molecular classification of cutaneous malignant melanoma by gene expression profiling.

Authors:  M Bittner; P Meltzer; Y Chen; Y Jiang; E Seftor; M Hendrix; M Radmacher; R Simon; Z Yakhini; A Ben-Dor; N Sampas; E Dougherty; E Wang; F Marincola; C Gooden; J Lueders; A Glatfelter; P Pollock; J Carpten; E Gillanders; D Leja; K Dietrich; C Beaudry; M Berens; D Alberts; V Sondak
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

10.  Effect of the human cytomegalovirus IE86 protein on expression of E2F-responsive genes: a DNA microarray analysis.

Authors:  Yoon-Jae Song; Mark F Stinski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

View more
  146 in total

1.  siRNA-mediated down-regulation of P-glycoprotein in a Xenograft tumor model in NOD-SCID mice.

Authors:  Meysam Abbasi; Hamidreza Montazeri Aliabadi; Elaine H Moase; Afsaneh Lavasanifar; Kamaljit Kaur; Raymond Lai; Charles Doillon; Hasan Uludağ
Journal:  Pharm Res       Date:  2011-06-03       Impact factor: 4.200

Review 2.  RNA interference: biology, mechanism, and applications.

Authors:  Neema Agrawal; P V N Dasaradhi; Asif Mohmmed; Pawan Malhotra; Raj K Bhatnagar; Sunil K Mukherjee
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

3.  The specifics of small interfering RNA specificity.

Authors:  Andrew Dillin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-16       Impact factor: 11.205

4.  Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference.

Authors:  Xian Chu Kong; Patrizia Barzaghi; Markus A Ruegg
Journal:  EMBO Rep       Date:  2004-01-16       Impact factor: 8.807

5.  Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs).

Authors:  Stephan P Persengiev; Xiaochun Zhu; Michael R Green
Journal:  RNA       Date:  2004-01       Impact factor: 4.942

6.  Inducible suppression of Fgfr2 and Survivin in ES cells using a combination of the RNA interference (RNAi) and the Cre-LoxP system.

Authors:  Xavier Coumoul; Wenmei Li; Rui-Hong Wang; Chuxia Deng
Journal:  Nucleic Acids Res       Date:  2004-06-15       Impact factor: 16.971

7.  DEQOR: a web-based tool for the design and quality control of siRNAs.

Authors:  Andreas Henschel; Frank Buchholz; Bianca Habermann
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

Review 8.  Optimizing RNA interference for application in mammalian cells.

Authors:  René H Medema
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

9.  Efficient RNA interference depends on global context of the target sequence: quantitative analysis of silencing efficiency using Eulerian graph representation of siRNA.

Authors:  Petr Pancoska; Zdenek Moravek; Ute M Moll
Journal:  Nucleic Acids Res       Date:  2004-03-01       Impact factor: 16.971

10.  Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.

Authors:  Mona D Lee; Yuhong She; Michael J Soskis; Christopher P Borella; Jeffrey R Gardner; Paula A Hayes; Benzon M Dy; Mark L Heaney; Mark R Philips; William G Bornmann; Francis M Sirotnak; David A Scheinberg
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.